Liposarcoma CT: Difference between revisions
Jump to navigation
Jump to search
| Line 19: | Line 19: | ||
| style="padding: 5px 5px; background: #4479BA; font-weight: bold; width: 100px; text-align:center" | {{fontcolor|#FFF|Lymph Nodes Around the Tumor }} | | style="padding: 5px 5px; background: #4479BA; font-weight: bold; width: 100px; text-align:center" | {{fontcolor|#FFF|Lymph Nodes Around the Tumor }} | ||
| style="padding: 5px 5px; background: #4479BA; font-weight: bold; width: 100px; text-align:center" | {{fontcolor|#FFF|Calcifications}} | | style="padding: 5px 5px; background: #4479BA; font-weight: bold; width: 100px; text-align:center" | {{fontcolor|#FFF|Calcifications}} | ||
| style="padding: 5px 5px; background: #4479BA; font-weight: bold; width: 100px; text-align:center" | {{fontcolor|#FFF|Necrosis}} | |||
|- | |- | ||
| style="background: #4479BA; font-weight: bold;" | {{fontcolor|#FFF|Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL)}} | | style="background: #4479BA; font-weight: bold;" | {{fontcolor|#FFF|Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL)}} | ||
| Line 26: | Line 27: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | ++ | | style="padding: 5px 5px; background: #F5F5F5;" | ++ | ||
| style="padding: 5px 5px; background: #DCDCDC;" | Few/none | | style="padding: 5px 5px; background: #DCDCDC;" | Few/none | ||
| style="padding: 5px 5px; background: #F5F5F5;" | + | |||
|- | |- | ||
| style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF|Dedifferentiated liposarcoma (DDL)}} | | style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF|Dedifferentiated liposarcoma (DDL)}} | ||
| Line 33: | Line 35: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | +++ | | style="padding: 5px 5px; background: #F5F5F5;" | +++ | ||
| style="padding: 5px 5px; background: #DCDCDC;" | Few/none | | style="padding: 5px 5px; background: #DCDCDC;" | Few/none | ||
| style="padding: 5px 5px; background: #F5F5F5;" | ++ | |||
|- | |- | ||
| style="background: #4479BA; font-weight: bold; width: 100px;" | {{fontcolor|#FFF|Myxoid/round cell liposarcoma (ML/RCL)}} | | style="background: #4479BA; font-weight: bold; width: 100px;" | {{fontcolor|#FFF|Myxoid/round cell liposarcoma (ML/RCL)}} | ||
| Line 39: | Line 42: | ||
| style="padding: 5px 5px; background: #DCDCDC;" | 25-50% | | style="padding: 5px 5px; background: #DCDCDC;" | 25-50% | ||
| style="padding: 5px 5px; background: #F5F5F5;" | + | | style="padding: 5px 5px; background: #F5F5F5;" | + | ||
| style="padding: 5px 5px; background: #DCDCDC;" | | | style="padding: 5px 5px; background: #DCDCDC;" | Common | ||
| style="padding: 5px 5px; background: #F5F5F5;" | +++ | |||
|- | |- | ||
| style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF|Pleomorphic liposarcoma (PL)}} | | style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF|Pleomorphic liposarcoma (PL)}} | ||
| Line 47: | Line 51: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | + | | style="padding: 5px 5px; background: #F5F5F5;" | + | ||
| style="padding: 5px 5px; background: #DCDCDC;" | Few/none | | style="padding: 5px 5px; background: #DCDCDC;" | Few/none | ||
| style="padding: 5px 5px; background: #F5F5F5;" | + | |||
|- | |- | ||
| style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF|Mixed-type liposarcoma}} | | style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF|Mixed-type liposarcoma}} | ||
| Line 53: | Line 58: | ||
| style="padding: 5px 5px; background: #DCDCDC;" | 30-60% | | style="padding: 5px 5px; background: #DCDCDC;" | 30-60% | ||
| style="padding: 5px 5px; background: #F5F5F5;" | ++ | | style="padding: 5px 5px; background: #F5F5F5;" | ++ | ||
| style="padding: 5px 5px; background: #DCDCDC;" | | | style="padding: 5px 5px; background: #DCDCDC;" | Common | ||
| style="padding: 5px 5px; background: #F5F5F5;" | + | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" colspan=6|<small> Table adapted from CT Manifestations in Histologic Subtypes of Retroperitoneal Liposarcoma<ref>{{Cite journal | | style="padding: 5px 5px; background: #F5F5F5;" colspan=6|<small> Table adapted from CT Manifestations in Histologic Subtypes of Retroperitoneal Liposarcoma<ref>{{Cite journal | ||
Revision as of 18:35, 19 September 2014
|
Liposarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Liposarcoma CT On the Web |
|
American Roentgen Ray Society Images of Liposarcoma CT |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
CT Scan
- Imaging findings of liposarcoma are frequently characteristic.
- Focal or diffuse areas of fat associated with nonlipomatous components are commonly detected on computed tomographic or magnetic resonance images.
- The appearance and morphologic relationship between these areas frequently allow identification of the specific histologic subtype of liposarcoma.
| Subtypes | Density | Margins | Fat Content | Lymph Nodes Around the Tumor | Calcifications | Necrosis |
| Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) | Fat | Smooth regular | > 65% | ++ | Few/none | + |
| Dedifferentiated liposarcoma (DDL) | Mixed | Rough irregular | 30-60% | +++ | Few/none | ++ |
| Myxoid/round cell liposarcoma (ML/RCL) | Mixed | Rough irregular | 25-50% | + | Common | +++ |
| Pleomorphic liposarcoma (PL) | Soft tissue | Incomplete irregular | 6-25% | + | Few/none | + |
| Mixed-type liposarcoma | Mixed | Smooth regular | 30-60% | ++ | Common | + |
| Table adapted from CT Manifestations in Histologic Subtypes of Retroperitoneal Liposarcoma[1] | ||||||
References
- ↑ Jing Lu, Qin Qin, Liang-Liang Zhan, Xi Yang, Qing Xu, Jing Yu, Li-Na Dou, Hao Zhang, Yan Yang, Xiao-Chen Chen, Yue-Hua Yang, Hong-Yan Cheng & Xin-Chen Sun (2014). "Computed tomography manifestations of histologic subtypes of retroperitoneal liposarcoma". Asian Pacific journal of cancer prevention : APJCP. 15 (15): 6041–6046. PMID 25124571.